CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiencyREDDY, S. M; WINSTON, D. J; TERRITO, M. C et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 6, pp 979-984, issn 0268-3369, 6 p.Article

Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipientsWINSTON, D. J; HO, W. G; BARTONI, K et al.Bone marrow transplantation (Basingstoke). 1993, Vol 12, Num 3, pp 283-288, issn 0268-3369Article

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipientsWINSTON, D. J; WIRIN, D; SHAKED, A et al.Lancet (British edition). 1995, Vol 346, Num 8967, pp 69-74, issn 0140-6736Article

Ofloxacin versus vancomycin/Polymyxin for prevention of infectious in granulocytopenic patientsWINSTON, D. J; HO, W. G; BRUCKNER, D. A et al.The American journal of medicine. 1990, Vol 88, Num 1, pp 36-42, issn 0002-9343Article

Bone marrow transplantation in patients with leukaemia previously transfused with blood products from family membersHO, W. G; CHAMPLIN, R. E; WINSTON, D. J et al.British journal of haematology. 1987, Vol 67, Num 1, pp 67-70, issn 0007-1048Article

Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infectionsWINSTON, D. J; MCGRATTAN, M. A; BUSUTTIL, R. W et al.Antimicrobial agents and chemotherapy. 1984, Vol 26, Num 5, pp 673-677, issn 0066-4804Article

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled TrialWINSTON, D. J; SALIBA, F; NAVASA, M et al.American journal of transplantation (Print). 2012, Vol 12, Num 11, pp 3021-3030, issn 1600-6135, 10 p.Article

Randomized, placebo-controlled, double-blind, multicenter trial of efficacy and safety of granulocyte colony-stimulating factor in liver transplant recipientsWINSTON, D. J; FOSTER, P. F; SOMBERG, K. A et al.Transplantation. 1999, Vol 68, Num 9, pp 1298-1304, issn 0041-1337Article

Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejectionWINSTON, D. J; IMAGAWA, D. K; HOLT, C. D et al.Transplantation. 1995, Vol 60, Num 11, pp 1357-1360, issn 0041-1337Article

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients : results of a placebo-controlled, double-blind trialWINSTON, D. J; HO, W. G; BARTONI, K et al.Annals of internal medicine. 1993, Vol 118, Num 3, pp 179-184, issn 0003-4819Article

Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation∨ preliminary results of a controlled trialWINSTON, D. J; HO, W. G; CHENG-HSIEN LIN et al.The American journal of medicine. 1984, Vol 76, Num 3(A), pp 128-133, issn 0002-9343Article

Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patientsWINSTON, D. J; BARTONI, K; BRUCKNER, D. A et al.Clinical infectious diseases. 1998, Vol 26, Num 3, pp 576-583, issn 1058-4838Article

Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donorsSEU, P; WINSTON, D. J; HOLT, C. D et al.Transplantation. 1997, Vol 64, Num 11, pp 1614-1617, issn 0041-1337Article

Randomized comparison of ganciclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children receiving liver transplantsKING, S. M; SUPERINA, R; ANDREWS, W et al.Clinical infectious diseases. 1997, Vol 25, Num 5, pp 1173-1179, issn 1058-4838Conference Paper

Bone marrow transplantation for severe aplastic anemia: effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapyCHAMPLIN, R. E; HO, W. G; FEIG, S. A et al.Transplantation. 1990, Vol 49, Num 4, pp 720-724, issn 0041-1337, 5 p.Article

Current approaches to management of infections in bone marrow transplantsWINSTON, D. J; HO, W. G; CHAMPLIN, R. E et al.European journal of cancer & clinical oncology. 1989, Vol 25, pp S25-S35, issn 0277-5379, suppl. 2Article

Perineal gangrene in the patient with granulocytopenia: the importance of early diverting colostomyHIATT, J. R; KUCHENBECKER, S. L; WINSTON, D. J et al.Surgery. 1986, Vol 100, Num 5, pp 912-915, issn 0039-6060Article

Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantationWINSTON, D. J; ENG-SHANG HUANG; MILLER, M. J et al.Annals of internal medicine. 1985, Vol 102, Num 1, pp 16-20, issn 0003-4819Article

Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faeciumWINSTON, D. J; EMMANOUILIDES, C; KROEBER, A et al.Clinical infectious diseases. 2000, Vol 30, Num 5, pp 790-797, issn 1058-4838Article

Prophylactic fluconazole in liver transplant recipients : A Randomized, double-blind, placebo-controlled trialWINSTON, D. J; PAKRASI, A; BUSUTTIL, R. W et al.Annals of internal medicine. 1999, Vol 131, Num 10, pp 729-737, issn 0003-4819Article

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantationGOODMAN, J. L; WINSTON, D. J; POWDERLY, W. G et al.The New England journal of medicine. 1992, Vol 326, Num 13, pp 845-851, issn 0028-4793Article

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantationWINSTON, D. J; HO, W. G; CHENG-HSIEN LIN et al.Annals of internal medicine. 1987, Vol 106, Num 1, pp 12-18, issn 0003-4819Article

Infection and transfusion therapy in acute leukaemiaHO, W. G; WINSTON, D. J.Clinics in haematology. 1986, Vol 15, Num 3, pp 873-904, issn 0308-2261Article

Infections complications of bone marrow transplantationWINSTON, D. J; HO, W. G; CHAMPLIN, R. E et al.Experimental hematology. 1984, Vol 12, Num 3, pp 205-215, issn 0301-472XArticle

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patientsWINSTON, D. J; BARNES, R. C; HO, W. G et al.The American journal of medicine. 1984, Vol 77, pp 442-450, issn 0002-9343Article